vs
CNO Financial Group, Inc.（CNO）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
CNO Financial Group, Inc.的季度营收约是Rollins, Inc.的1.3倍（$1.1B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs 8.8%，领先3.1%），Rollins, Inc.同比增速更快（10.2% vs 4.2%），过去两年Rollins, Inc.的营收复合增速更高（0.8% vs -0.6%）
CNO金融集团是总部位于美国印第安纳州卡梅尔的金融服务控股公司，前身为康塞科公司。集团旗下保险子公司为美国超400万客户提供人寿保险、年金和补充健康保险产品，通过独立代理人、专属代理人，以及电视广告、直邮等直销触达用户。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
CNO vs ROL — 直观对比
营收规模更大
CNO
是对方的1.3倍
$906.4M
营收增速更快
ROL
高出6.0%
4.2%
净利率更高
ROL
高出3.1%
8.8%
两年增速更快
ROL
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $906.4M |
| 净利润 | $100.7M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | 15.2% | 16.1% |
| 净利率 | 8.8% | 11.9% |
| 营收同比 | 4.2% | 10.2% |
| 净利润同比 | -39.4% | 2.5% |
| 每股收益（稀释后） | $1.02 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNOROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.1B | $912.9M | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.2B | $999.5M | ||
| Q1 25 | $1.0B | $822.5M | ||
| Q4 24 | $1.1B | $832.2M | ||
| Q3 24 | $1.1B | $916.3M | ||
| Q2 24 | $1.1B | $891.9M |
净利润CNOROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $100.7M | $116.4M | ||
| Q3 25 | $23.1M | $163.5M | ||
| Q2 25 | $91.8M | $141.5M | ||
| Q1 25 | $13.7M | $105.2M | ||
| Q4 24 | $166.1M | $105.7M | ||
| Q3 24 | $9.3M | $136.9M | ||
| Q2 24 | $116.3M | $129.4M |
营业利润率CNOROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 15.2% | 17.5% | ||
| Q3 25 | 13.7% | 21.9% | ||
| Q2 25 | 9.8% | 19.8% | ||
| Q1 25 | 10.4% | 17.3% | ||
| Q4 24 | 15.8% | 18.1% | ||
| Q3 24 | 13.6% | 20.9% | ||
| Q2 24 | 13.9% | 20.4% |
净利率CNOROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 8.8% | 12.8% | ||
| Q3 25 | 1.9% | 15.9% | ||
| Q2 25 | 8.0% | 14.2% | ||
| Q1 25 | 1.4% | 12.8% | ||
| Q4 24 | 15.1% | 12.7% | ||
| Q3 24 | 0.8% | 14.9% | ||
| Q2 24 | 10.9% | 14.5% |
每股收益（稀释后）CNOROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $1.02 | $0.24 | ||
| Q3 25 | $0.24 | $0.34 | ||
| Q2 25 | $0.91 | $0.29 | ||
| Q1 25 | $0.13 | $0.22 | ||
| Q4 24 | $1.58 | $0.22 | ||
| Q3 24 | $0.09 | $0.28 | ||
| Q2 24 | $1.06 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $116.5M |
| 总债务越低越好 | — | $650.6M |
| 股东权益账面价值 | $2.6B | $1.4B |
| 总资产 | $38.8B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资CNOROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | — | $100.0M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | — | $123.0M | ||
| Q1 25 | — | $201.2M | ||
| Q4 24 | — | $89.6M | ||
| Q3 24 | — | $95.3M | ||
| Q2 24 | — | $106.7M |
总债务CNOROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CNOROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.6B | $1.4B | ||
| Q3 25 | $2.6B | $1.5B | ||
| Q2 25 | $2.5B | $1.4B | ||
| Q1 25 | $2.5B | $1.4B | ||
| Q4 24 | $2.5B | $1.3B | ||
| Q3 24 | $2.7B | $1.3B | ||
| Q2 24 | $2.4B | $1.2B |
总资产CNOROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $38.8B | $3.1B | ||
| Q3 25 | $38.3B | $3.2B | ||
| Q2 25 | $37.3B | $3.2B | ||
| Q1 25 | $37.4B | $2.9B | ||
| Q4 24 | $37.9B | $2.8B | ||
| Q3 24 | $37.6B | $2.8B | ||
| Q2 24 | $36.3B | $2.8B |
负债/权益比CNOROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $195.7M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | — | $111.2M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | 1.94× | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势，按日历期对齐
经营现金流CNOROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $195.7M | $164.7M | ||
| Q3 25 | $197.8M | $191.3M | ||
| Q2 25 | $145.5M | $175.1M | ||
| Q1 25 | $136.7M | $146.9M | ||
| Q4 24 | $191.0M | $188.2M | ||
| Q3 24 | $231.2M | $146.9M | ||
| Q2 24 | $110.9M | $145.1M |
自由现金流CNOROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $182.8M | ||
| Q2 25 | — | $168.0M | ||
| Q1 25 | — | $140.1M | ||
| Q4 24 | — | $184.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $136.4M |
自由现金流率CNOROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | — | 17.4% | ||
| Q3 25 | — | 17.8% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 15.3% |
资本支出强度CNOROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.0% |
现金转化率CNOROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 1.94× | 1.41× | ||
| Q3 25 | 8.56× | 1.17× | ||
| Q2 25 | 1.58× | 1.24× | ||
| Q1 25 | 9.98× | 1.40× | ||
| Q4 24 | 1.15× | 1.78× | ||
| Q3 24 | 24.86× | 1.07× | ||
| Q2 24 | 0.95× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNO
| Health Insurance Product Line | $496.4M | 43% |
| Life Insurance Segment | $268.8M | 24% |
| Other | $207.2M | 18% |
| Life And Annuity Insurance Product Line | $170.7M | 15% |
ROL
暂无分部数据
